Evidence map›Paper›PMID 34540157›Full record

ArticleIranian journal of microbiology2021

Exploring clinically isolated

Mohamed Ali Kassem, Amal Eissa Saafan, Faten Bayomy, Ahmed Osama El-Gendy

Open access · diamondAbstract read
In one paragraph

Article in Iranian journal of microbiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Mohamed Ali KassemDepartment of Microbiology and Immunology, Faculty of Pharmacy, Beni-Suef University, Beni-Suef, Egypt.
Amal Eissa SaafanDepartment of Microbiology and Immunology, Faculty of Pharmacy, Menoufeia University, Shebin El Kom, Egypt.
Faten BayomyDepartment of Immunogenetics, National Research Center, Cairo, Egypt.
Ahmed Osama El-GendyDepartment of Microbiology and Immunology, Faculty of Pharmacy, Beni-Suef University, Beni-Suef, Egypt.
Beni-Suef University · EGMenoufia University · EGNational Water Research Center · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

objectivesBacteriocins are considered alternative non-conventional antimicrobials produced by certain bacteria with activity against closely related species. The present study focuses on screening, characterization, and partial purification of bacteriocins produced by MATERIALS AND

methodsA total of 100

resultsTwenty isolates exhibited inhibitory effect against at least one indicator bacteria.

conclusionTo the best of our knowledge, this is the first study to report the production of micrococcin and α-circulocin from

Indexed as

AmonabactinBacteriocinsMicrococcinMicrococcus luteusStaphylococcus sp.

Identifiers

PMID34540157
PMCPMC8408034
OpenAlexW3155125663

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.